These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 22448230)

  • 1. Deleterious GRM1 mutations in schizophrenia.
    Ayoub MA; Angelicheva D; Vile D; Chandler D; Morar B; Cavanaugh JA; Visscher PM; Jablensky A; Pfleger KD; Kalaydjieva L
    PLoS One; 2012; 7(3):e32849. PubMed ID: 22448230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical modulation of mutant mGlu1 receptors derived from deleterious GRM1 mutations found in schizophrenics.
    Cho HP; Garcia-Barrantes PM; Brogan JT; Hopkins CR; Niswender CM; Rodriguez AL; Venable DF; Morrison RD; Bubser M; Daniels JS; Jones CK; Conn PJ; Lindsley CW
    ACS Chem Biol; 2014 Oct; 9(10):2334-46. PubMed ID: 25137254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clustered coding variants in the glutamate receptor complexes of individuals with schizophrenia and bipolar disorder.
    Frank RA; McRae AF; Pocklington AJ; van de Lagemaat LN; Navarro P; Croning MD; Komiyama NH; Bradley SJ; Challiss RA; Armstrong JD; Finn RD; Malloy MP; MacLean AW; Harris SE; Starr JM; Bhaskar SS; Howard EK; Hunt SE; Coffey AJ; Ranganath V; Deloukas P; Rogers J; Muir WJ; Deary IJ; Blackwood DH; Visscher PM; Grant SG
    PLoS One; 2011 Apr; 6(4):e19011. PubMed ID: 21559497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of a Novel TRMT1 Gene Mutation and Rare GRM1 Gene Defect in Intellectual Disability in Two Azeri Families.
    Davarniya B; Hu H; Kahrizi K; Musante L; Fattahi Z; Hosseini M; Maqsoud F; Farajollahi R; Wienker TF; Ropers HH; Najmabadi H
    PLoS One; 2015; 10(8):e0129631. PubMed ID: 26308914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.
    Mehta MS; Dolfi SC; Bronfenbrener R; Bilal E; Chen C; Moore D; Lin Y; Rahim H; Aisner S; Kersellius RD; Teh J; Chen S; Toppmeyer DL; Medina DJ; Ganesan S; Vazquez A; Hirshfield KM
    PLoS One; 2013; 8(7):e69851. PubMed ID: 23922822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Variant in
    Protasova MS; Andreeva TV; Klyushnikov SA; Illarioshkin SN; Rogaev EI
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues.
    Ali S; Shourideh M; Koochekpour S
    PLoS One; 2014; 9(7):e103204. PubMed ID: 25062106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale case-control study of a functional polymorphism in the glutamate receptor, metabotropic 3 gene in patients with schizophrenia.
    Nunokawa A; Watanabe Y; Kitamura H; Kaneko N; Arinami T; Ujike H; Inada T; Iwata N; Kunugi H; Itokawa M; Ozaki N; Someya T
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):239-40. PubMed ID: 18412850
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic inactivation of mGlu5 receptor improves motor coordination in the Grm1
    Bossi S; Musante I; Bonfiglio T; Bonifacino T; Emionite L; Cerminara M; Cervetto C; Marcoli M; Bonanno G; Ravazzolo R; Pittaluga A; Puliti A
    Neurobiol Dis; 2018 Jan; 109(Pt A):44-53. PubMed ID: 28982591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabotropic glutamate receptor 1, GRM1: evaluation as a candidate gene for inherited forms of cerebellar ataxia.
    Rossi PI; Vaccari CM; Terracciano A; Doria-Lamba L; Facchinetti S; Priolo M; Ayuso C; De Jorge L; Gimelli S; Santorelli FM; Ravazzolo R; Puliti A
    J Neurol; 2010 Apr; 257(4):598-602. PubMed ID: 19924463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exome sequencing in families with severe mental illness identifies novel and rare variants in genes implicated in Mendelian neuropsychiatric syndromes.
    Ganesh S; Ahmed P H; Nadella RK; More RP; Seshadri M; Viswanath B; Rao M; Jain S; ; Mukherjee O
    Psychiatry Clin Neurosci; 2019 Jan; 73(1):11-19. PubMed ID: 30367527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No evidence for association between polymorphisms in GRM3 and schizophrenia.
    Norton N; Williams HJ; Dwyer S; Ivanov D; Preece AC; Gerrish A; Williams NM; Yerassimou P; Zammit S; O'Donovan MC; Owen MJ
    BMC Psychiatry; 2005 May; 5():23. PubMed ID: 15892884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel truncating variant p.(Arg297*) in the GRM1 gene causing autosomal-recessive cerebellar ataxia with juvenile-onset.
    Cabet S; Putoux A; Carneiro M; Labalme A; Sanlaville D; Guibaud L; Lesca G
    Eur J Med Genet; 2019 Oct; 62(10):103726. PubMed ID: 31319223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells.
    Martino JJ; Wall BA; Mastrantoni E; Wilimczyk BJ; La Cava SN; Degenhardt K; White E; Chen S
    Oncogene; 2013 Sep; 32(37):4366-76. PubMed ID: 23085756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Support for the N-methyl-D-aspartate receptor hypofunction hypothesis of schizophrenia from exome sequencing in multiplex families.
    Timms AE; Dorschner MO; Wechsler J; Choi KY; Kirkwood R; Girirajan S; Baker C; Eichler EE; Korvatska O; Roche KW; Horwitz MS; Tsuang DW
    JAMA Psychiatry; 2013 Jun; 70(6):582-90. PubMed ID: 23553203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population.
    Chen Q; He G; Chen Q; Wu S; Xu Y; Feng G; Li Y; Wang L; He L
    Schizophr Res; 2005 Feb; 73(1):21-6. PubMed ID: 15567072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.
    Teh JL; Shah R; La Cava S; Dolfi SC; Mehta MS; Kongara S; Price S; Ganesan S; Reuhl KR; Hirshfield KM; Karantza V; Chen S
    Breast Cancer Res Treat; 2015 May; 151(1):57-73. PubMed ID: 25859923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia.
    Ohtsuki T; Koga M; Ishiguro H; Horiuchi Y; Arai M; Niizato K; Itokawa M; Inada T; Iwata N; Iritani S; Ozaki N; Kunugi H; Ujike H; Watanabe Y; Someya T; Arinami T
    Schizophr Res; 2008 Apr; 101(1-3):9-16. PubMed ID: 18329248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA sequence variants in the metabotropic glutamate receptor 3 and risk to schizophrenia: an association study.
    Schwab SG; Plummer C; Albus M; Borrmann-Hassenbach M; Lerer B; Trixler M; Maier W; Wildenauer DB
    Psychiatr Genet; 2008 Feb; 18(1):25-30. PubMed ID: 18197082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.